MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer. - Wikidata - awgldk - TriplyDB

MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer.

MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer.

http://www.wikidata.org/entity/Q34357796

about

Prediction and preliminary validation of oncogene regulation by miRNAs Blockade of Wnt-1 signaling leads to anti-tumor effects in hepatocellular carcinoma cells MicroRNA-26a/b and their host genes cooperate to inhibit the G1/S transition by activating the pRb protein PLAGL2 regulates Wnt signaling to impede differentiation in neural stem cells and gliomas Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model The role of mutation in the new cancer paradigm Brief inactivation of c-Myc is not sufficient for sustained regression of c-Myc-induced tumours of pancreatic islets and skin epidermis Stem cell technology in breast cancer: current status and potential applications SGF29 and Sry pathway in hepatocarcinogenesis MYC and metabolism on the path to cancer Mouse models of liver cancer: Progress and recommendations The cancer stem cell niche: how essential is the niche in regulating stemness of tumor cells?The genetic and epigenetic alterations in human hepatocellular carcinoma: a recent update In vivo bioluminescent imaging (BLI): noninvasive visualization and interrogation of biological processes in living animals Nonalcoholic fatty liver disease: new treatments Small-molecule inhibitors of the Myc oncoprotein MYC activation is a hallmark of cancer initiation and maintenance Development and characterization of a preclinical model of breast cancer lung micrometastatic to macrometastatic progression On metabolic reprogramming and tumor biology: A comprehensive survey of metabolism in breast cancer Genetically engineered mouse models in oncology research and cancer medicine The cancer stem cell niche--there goes the neighborhood?Tumor-vascular interactions and tumor dormancy Role of DLC1 tumor suppressor gene and MYC oncogene in pathogenesis of human hepatocellular carcinoma: potential prospects for combined targeted therapeutics (review)Identification of cytotoxic drugs that selectively target tumor cells with MYC overexpression Stress response gene ATF3 is a target of c-myc in serum-induced cell proliferation Mammalian Mst1 and Mst2 kinases play essential roles in organ size control and tumor suppression Impact of hydrodynamic injection and phiC31 integrase on tumor latency in a mouse model of MYC-induced hepatocellular carcinoma N-Myc Induces an EZH2-Mediated Transcriptional Program Driving Neuroendocrine Prostate Cancer Global gene profiling of spontaneous hepatocellular carcinoma in B6C3F1 mice: similarities in the molecular landscape with human liver cancer An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors MYC on the path to cancer Aberrant expression of ID2 protein and its correlation with EBV-LMP1 and P16(INK4A) in classical Hodgkin lymphoma in China.Anti-proliferative activity of the quassinoid NBT-272 in childhood medulloblastoma cells Combined Inactivation of MYC and K-Ras oncogenes reverses tumorigenesis in lung adenocarcinomas and lymphomas.Combined analysis of murine and human microarrays and ChIP analysis reveals genes associated with the ability of MYC to maintain tumorigenesis Hepatotoxin-induced changes in the adult murine liver promote MYC-induced tumorigenesis c-Myc is required for maintenance of glioma cancer stem cells.RNA interference-mediated c-MYC inhibition prevents cell growth and decreases sensitivity to radio- and chemotherapy in childhood medulloblastoma cells.Regulation of transgenes in three-dimensional cultures of primary mouse mammary cells demonstrates oncogene dependence and identifies cells that survive deinduction.Stem cells in hepatocarcinogenesis: evidence from genomic data

P2860

Q21262991-403B24E1-2BE6-441B-B05C-290723FF17E1 Q24318355-016C478C-0728-483D-8B48-417BA67DFFB7 Q24601263-C7D795F6-0AFD-437F-B9AA-6C688B19D60C Q24615768-5AD01DD9-187F-4451-89CE-AC5B075977DB Q24655262-E4BE27FA-C0E8-42E8-9CF0-E493AD884532 Q24800150-12EB3B35-CF57-401C-82D2-4BF08563E212 Q24801681-C5B5FDFD-0ECE-4733-BFB3-F35D41166DE8 Q26746223-7F4170F3-CF3A-4293-8130-F64DDA7AF189 Q26795760-79BD9930-0363-4C38-ADA7-DDA0ACDFE7BE Q26798086-6889BA39-AECF-4E44-AF29-E2EAE15E9A67 Q26799788-55BE1550-FD6C-400E-A707-5CA1B5D03662 Q26824147-037A5B68-0EC8-4C5F-A6C1-9A163D953F77 Q27003050-1EF85F3B-3EE7-4A12-8426-C0693E13F1F8 Q27006069-798254B4-D05A-485D-AB99-9D039C872C10 Q27021161-1F318030-D463-4461-9AB4-40716AA474E0 Q27025648-853389AC-237C-4B63-8EA8-1F3B9FDDD8FF Q27026026-71BF49E0-3AE6-4C2E-AAE0-1D896E7AAB61 Q27325140-0C8B68ED-D70C-4B9C-8865-5287B1188F7F Q28072798-1FAF33E4-87D7-434A-BD0A-2B22E3924469 Q28079323-2F7EE896-01BE-4130-9C04-C70307A34386 Q28244178-6FD8DD5F-D141-4FED-AC91-491C48CA7526 Q28295975-35A57918-80BC-4D26-AD6A-0A8106084B68 Q28394917-CFE24304-05CD-4D18-9993-4E4FCDE447BF Q28478132-026B0995-E21C-4AF7-9E16-F5A003BCFCB3 Q28572315-9B310B6C-29D0-4C55-AF4B-C15B708B9480 Q28591557-6DF294F2-2245-4A83-916C-A9168B11DDB0 Q28750796-05494117-04BC-41F6-9BFB-1B6F8CEABCAF Q28771715-3488F2CA-B878-44AA-8C88-54490092917F Q28829385-0FD9F941-DF89-461E-9363-2637A6BEA6F3 Q29615393-5F5CF345-FB0E-4060-8606-43E2C17274FD Q29619979-D9804270-3A46-47B8-AB4A-3ED9AC05EB4A Q30855570-02A0C36A-3385-4430-876E-DD4737D627AA Q33270402-14A6813B-ADF8-4C36-9881-A6F760031511 Q33332189-A43C2FBF-397D-4B34-8AB5-E539D9E583AE Q33340980-559CC254-20B4-4323-989A-83D195DB9207 Q33344462-2D5A205C-A9EA-4FAD-AF61-F4DB1BD023B4 Q33385645-D06E8AC5-F8B6-409D-9F22-1A075D68B9AA Q33398834-9FD836FA-8E6E-404A-99EF-8572877FB24E Q33482643-0765FBAA-4438-40F1-A760-9975F4EA585A Q33533408-AE901AF1-070C-4A8B-83A6-0DA4D18C5BE6

P2860

MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer.

http://www.wikidata.org/entity/Q34357796

description

2004 nî lūn-bûn

@nan

2004 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

MYC inactivation uncovers plur ...... ancy in hepatocellular cancer.

@ast

MYC inactivation uncovers plur ...... ancy in hepatocellular cancer.

@en

MYC inactivation uncovers plur ...... ancy in hepatocellular cancer.

@nl

type

label

MYC inactivation uncovers plur ...... ancy in hepatocellular cancer.

@ast

MYC inactivation uncovers plur ...... ancy in hepatocellular cancer.

@en

MYC inactivation uncovers plur ...... ancy in hepatocellular cancer.

@nl

prefLabel

MYC inactivation uncovers plur ...... ancy in hepatocellular cancer.

@ast

MYC inactivation uncovers plur ...... ancy in hepatocellular cancer.

@en

MYC inactivation uncovers plur ...... ancy in hepatocellular cancer.

@nl

P1433

Q34357796-84A2A514-985A-4873-B2D2-32FA6684A8CA

P1476

Q34357796-35174D80-0A80-49AE-BB54-F207BAAB792A

P2093

Q34357796-0ABD379F-DD9E-46D6-B913-7CB43E4D613F

Q34357796-132C88FE-B9C6-49EF-84BD-0219CD7900BB

Q34357796-16A015E0-BC9B-44A4-99E5-127985D795FE

Q34357796-2E911DE4-6800-4F56-949D-2F13162DD8D3

Q34357796-5BF692AB-C3F4-498B-8FF8-1374380AB270

Q34357796-792C5214-3B2C-4CD1-94FA-AE455342CA4C

Q34357796-9CD51780-E36B-451A-ABF9-D6D4C6EE2636

Q34357796-C697B270-CEE6-4678-97CB-0E269704A56B

Q34357796-DE66A300-CDD9-4B77-BB7A-22C7939AADF2

Q34357796-EC82B4F7-6407-4BAC-81C2-44D0C3095CC8

P2888

Q34357796-53D50BCE-BB7C-4CB3-A923-E9671AD8D28D

P304

Q34357796-5EF375B4-6DC9-4709-ADA0-3018BFB0E1A9

P31

Q34357796-4620AFFB-32CE-4199-AB42-0569AB288786

P356

Q34357796-F5C05E93-07A4-4917-8472-06700D30FD0B

P407

Q34357796-146FEB34-2361-459E-A0F1-A52DC17D9F4A

P433

Q34357796-1DAF0784-169A-42C8-B8A6-FF3F86AEC550

P478

Q34357796-3C680CEF-FC16-40BC-8BA9-CEAD28508CDD

P50

Q34357796-13EC1569-B17C-4563-8C75-6A882D66861E

Q34357796-4AADB254-C3C9-4AF4-ACD7-3CAC0076FE39

P577

Q34357796-A4CF6CAA-07B3-44D5-A1B9-967F7D18D2D7

P5875

Q34357796-61B78E0A-A833-450B-8D0A-139C18B9C582

P6179

Q34357796-D14D772A-3C88-4E8A-8A6E-0FB0289DB723

P698

Q34357796-952BF3F0-4496-4CB5-A142-B3F02F41EAD1

P356

P1433

P1476

MYC inactivation uncovers plur ...... ancy in hepatocellular cancer.

@en

P2093

Alexander D Borowsky

http://www.w3.org/2001/XMLSchema#string

Andrew M Kopelman

http://www.w3.org/2001/XMLSchema#string

Asa Karlsson

http://www.w3.org/2001/XMLSchema#string

Boris Ruebner

http://www.w3.org/2001/XMLSchema#string

Catherine M Shachaf

http://www.w3.org/2001/XMLSchema#string

Constadina Arvanitis

http://www.w3.org/2001/XMLSchema#string

Dean W Felsher

http://www.w3.org/2001/XMLSchema#string

J Michael Bishop

http://www.w3.org/2001/XMLSchema#string

Qiwei Yang

http://www.w3.org/2001/XMLSchema#string

Robert D Cardiff

http://www.w3.org/2001/XMLSchema#string

P2888

P304

1112-1117

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NATURE03043

http://www.w3.org/2001/XMLSchema#string

P407

P433

7012

http://www.w3.org/2001/XMLSchema#string

P478

431

http://www.w3.org/2001/XMLSchema#string

P50

Michael H Bachmann

Christopher H. Contag

P577

2004-10-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8239872

http://www.w3.org/2001/XMLSchema#string

P6179

1008158389

http://www.w3.org/2001/XMLSchema#string

P698

15475948

http://www.w3.org/2001/XMLSchema#string